POLITICO reporters discuss the policy ramifications of CBD and marijuana legalization. Plus: Three health issues to watch in the 2020 campaign.
With Congress on recess, POLITICO reporters break down a series of recent stories.
First, POLITICO's Sarah Owermohle and Paul Demko discuss the FDA's landmark hearing on CBD and separate efforts to legalize marijuana. (Starts at the 0:50 mark.)
Then, POLITICO's Rachana Pradhan and Adam Cancryn join Dan to review the policy fights over abortion access, drug pricing and LGBTQ protections, and how they're playing ahead of 2020 election campaigns. (Starts at the 16:25 mark.)